Tokyo Tape
Sign in
← Kringle Pharma

Annual report

4884.TEDINET S100XBJD
Period2024-10-01 → 2025-09-30
Filed2025-12-19
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 77
MetricValuePeriodScopeSource row
Revenue¥72m2024-10-01 → 2025-09-30StandaloneNet sales
Revenue¥80m2023-10-01 → 2024-09-30StandaloneNet sales
Revenue¥69m2022-10-01 → 2023-09-30vStandaloneNet sales (5-year summary)
Revenue¥392m2021-10-01 → 2022-09-30vStandaloneNet sales (5-year summary)
Revenue¥290m2020-10-01 → 2021-09-30dStandaloneNet sales (5-year summary)
Operating income−¥909m2024-10-01 → 2025-09-30StandaloneOperating income
Operating income−¥818m2023-10-01 → 2024-09-30StandaloneOperating income
Ordinary income−¥915m2024-10-01 → 2025-09-30StandaloneOrdinary income
Ordinary income−¥755m2023-10-01 → 2024-09-30StandaloneOrdinary income
Ordinary income−¥853m2022-10-01 → 2023-09-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥330m2021-10-01 → 2022-09-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥300m2020-10-01 → 2021-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥915m2024-10-01 → 2025-09-30StandaloneIncome before income taxes
Profit before tax−¥755m2023-10-01 → 2024-09-30StandaloneIncome before income taxes
Net income−¥916m2024-10-01 → 2025-09-30StandaloneProfit loss
Net income−¥756m2023-10-01 → 2024-09-30StandaloneProfit loss
Net income−¥854m2022-10-01 → 2023-09-30vStandaloneNet income loss (5-year summary)
Net income−¥332m2021-10-01 → 2022-09-30vStandaloneNet income loss (5-year summary)
Net income−¥301m2020-10-01 → 2021-09-30dStandaloneNet income loss (5-year summary)
Total assets¥2.1bnat 2025-09-30StandaloneAssets
Total assets¥2.8bnat 2024-09-30StandaloneAssets
Total assets¥2.6bnat 2023-09-30vStandaloneTotal assets (5-year summary)
Total assets¥3.2bnat 2022-09-30vStandaloneTotal assets (5-year summary)
Total assets¥2.6bnat 2021-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥770mat 2025-09-30StandaloneLiabilities
Total liabilities¥649mat 2024-09-30StandaloneLiabilities
Net assets / equity¥1.3bnat 2025-09-30StandaloneNet assets
Net assets / equity¥2.1bnat 2024-09-30StandaloneNet assets
Net assets / equity¥2.0bnat 2023-09-30vStandaloneNet assets
Net assets / equity¥2.8bnat 2022-09-30vStandaloneNet assets (5-year summary)
Net assets / equity¥2.5bnat 2021-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥1.6bnat 2025-09-30StandaloneCash and deposits
Cash and deposits¥2.3bnat 2024-09-30StandaloneCash and deposits
Cash & equivalents¥991mat 2025-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2023-09-30vStandaloneCash and cash equivalents
Cash & equivalents¥2.5bnat 2022-09-30vStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.1bnat 2021-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥756m2024-10-01 → 2025-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥661m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥689m2022-10-01 → 2023-09-30vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥16m2021-10-01 → 2022-09-30vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥561m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥154m2024-10-01 → 2025-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥121m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥121m2022-10-01 → 2023-09-30vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥254m2021-10-01 → 2022-09-30vStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥84m2024-10-01 → 2025-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥838m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥69m2022-10-01 → 2023-09-30vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥603m2021-10-01 → 2022-09-30vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥596m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-133.922024-10-01 → 2025-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-118.212023-10-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-158.462022-10-01 → 2023-09-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-68.332021-10-01 → 2022-09-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-72.512020-10-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥182.3at 2025-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥306.87at 2024-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥363.45at 2023-09-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥517.75at 2022-09-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥578.17at 2021-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio61.5%at 2025-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio75.8%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio76.6%at 2023-09-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio86.8%at 2022-09-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio95.1%at 2021-09-30dStandaloneEquity to asset ratio (5-year summary)
Shares issued7,018,200at 2025-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued6,810,700at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued5,522,200at 2023-09-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued5,380,700at 2022-09-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued4,334,700at 2021-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees17at 2025-09-30StandaloneNumber of employees
Employees15at 2024-09-30StandaloneNumber of employees
Employees13at 2023-09-30vStandaloneNumber of employees
Employees12at 2022-09-30vStandaloneNumber of employees
Employees11at 2021-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 770
ItemContextValueUnit
Critical contracts (text)FilingDateInstantText · Plus
Research and development activities (text)FilingDateInstantText · Plus
Overview of capital expenditures etc (text)FilingDateInstantText · Plus
Major facilities (text)FilingDateInstantText · Plus
Planned additions retirements etc of facilities (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所（グロース市場）
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)単元株式数は100株であります。
Details of employee share option program (text)FilingDateInstantText · Plus
Description of rights plan (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Shareholding by shareholder category (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentYearInstant_No1MajorShareholdersMember
Original text (Japanese)日本全薬工業株式会社
Address major shareholdersCurrentYearInstant_No1MajorShareholdersMember
Original text (Japanese)福島県郡山市安積町笹川字平ノ上１－１
Name major shareholdersCurrentYearInstant_No2MajorShareholdersMemberText · Plus
Address major shareholdersCurrentYearInstant_No2MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)CYBERDYNE株式会社
Address major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)茨城県つくば市学園南２丁目２－１
Name major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)山田　哲夫
Address major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)東京都小金井市
Name major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)野村證券株式会社
Address major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)東京都中央区日本橋１丁目１３番１号
Name major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)高山　二郎
Address major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)大阪府東大阪市
Name major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)上田八木短資株式会社
Address major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)大阪市中央区高麗橋２丁目４－２
Name major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)丸石製薬株式会社
Address major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)大阪市鶴見区今津中２丁目４－２
Name major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)株式会社リプロセル
Address major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)横浜市港北区新横浜３丁目８－11
Name major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)安達　喜一
Address major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)大阪府箕面市
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithFullVotingRightsOtherMember
Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式であります。単元株式数は100株であります。
Description issued shares voting rightsCurrentYearInstant_SharesLessThanOneUnitMember－
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese)クリングルファーマ株式会社
Address of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese)大阪府茨木市彩都あさぎ七丁目７番15号彩都バイオインキュベータ
Classes of shares etc (text)FilingDateInstantText · Plus
Acquisitions by resolution of shareholders meeting (text)FilingDateInstantText · Plus
Acquisitions by resolution of board of directors meeting (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-09-30pass
balance sheet identitynon_consolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · net assetsnon_consolidated 2025-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · operating cash flownon_consolidated 2024-10-01/2025-09-30pass
statement vs summary · revenuenon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2024-10-01/2025-09-30pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass
statement vs summary · total assetsnon_consolidated 2025-09-30pass